Skip to main content
. 2020 Oct 14;57(6):1319–1332. doi: 10.3892/ijo.2020.5133

Figure 2.

Figure 2

Expression of ETV1 and JMJD2A mRNA in colorectal cancer. (A) Upregulation of ETV1 mRNA in colorectal tumors. Data were from the study by Hong et al (77). (B) Analogous in microarray data from the study published by Skrzypczak et al (78). (C) Higher ETV1 expression was associated with a reduced 5-year survival according to the microarray data from the study by Smith et al (79). (D) JMJD2A mRNA levels were downregulated in colorectal carcinomas. Data were from the Cancer Genome Atlas (81). (E) Analogous in microarray data published in the study by Skrzypczak et al (78). (F) Decreased survival (5 years) was associated with increased JMJD2A mRNA levels. Microarray data retrieved from the study by Smith et al (79). Statistical significance was assessed with unpaired, two-tailed Student's t test. JMJD, Jumonji C domain-containing protein.